2021 Best In KLAS Acute Care EMR Large Hospital / IDN

Performance

Small-Hospital EHR (1–200 Beds) 2024

31 October 24 | Paul Warburton and Tyson Blauer

Small acute care organizations face unique challenges—such as financial constraints and limited internal resources—that impact or even delay their EHR purchase decisions. As a result, according to KLAS’ 2024 acute care EHR market share report (which tracks all hospital EHR wins and losses), 42% of the small independent hospitals (1–200 beds) still use legacy systems. Still, progress is being made: between 2021 and 2023, KLAS validated go-forward EHR decisions made by 184 such hospitals (almost 14% of the market). This report examines how a sample of those organizations are faring with their new EHR, including what their decisions suggest about future buying energy in this space, how much value they have realized, and how their training experience has been. Note on Report Sample & Methodology: Data for this report comes from three main sources: (1) KLAS Decision Insights data, (2) KLAS market share data, and (3) KLAS performance data. KLAS Decision Insights data includes all EHR purchases from small standalone hospitals (1–200 beds) between August 2022 and August 2024. The rest of the data comes from a subset of small hospitals that have made an EHR purchase decision in the last three years and have been live for at least three months. Of the vendors with recent wins, only Epic, MEDITECH Expanse, Oracle Health, and TruBridge EHR have sufficient performance data to be included.

Over the last five years, there has been consistent energy around EPR investment and digital transformation in the UK and Ireland—on average, at least six healthcare organisations have made an EPR purchase decision each year. Going forward, activity will likely increase amid integrated care system (ICS) alignment, as over 50 trusts will look to upgrade or deploy their first EPR over the next few years. While going through the complex decision-making process, organisations frequently look for a partner that can provide not only core documentation and ordering functionalities but also additional clinical, administrative and ancillary modules to support their digital transformation. This report includes (1) an overview of the market share and customer satisfaction with EPR suppliers in the UK and Ireland and (2) a look at suppliers’ broader portfolios, diving into the performance and adoption of modules outside of core functionality.

When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Evident (CPSI) “complete look” provides a high-level analysis of the key products that make up Evident’s core enterprise suite and its supporting technology. (Other reports in the series do the same for Altera Digital Health [Allscripts] , Epic , MEDITECH , and Oracle Health [Cerner] .)

When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This MEDITECH Expanse “complete look” provides a high-level analysis of the key products that make up MEDITECH’s enterprise suite. (Other reports in the series do the same for Altera Digital Health [Allscripts] , Epic , Evident , and Oracle Health [Cerner] .) This report focuses on the core Expanse suite; data on MEDITECH’s MAGIC, C/S, and 6.x platforms is excluded.

	Overall performance score (100-point scale)	Trend (2020-2021)	Total evaluations	Culture	Loyalty	Operations	Product	Relationship	Value

Epic Care Inpatient EMR	89.3	0%	n=163	A	A	B	B+	A-	B+

MEDITECH Expanse Acute Care EMR	82.2	N/A	n=21	C	B+	B	B-	B	B

Oracle Health Cerner Millennium PowerChart/CommunityWorks Clinicals	74.5	0%	n=113	C	C+	C	C+	C+	D+

Altera Digital Health Allscripts Sunrise Acute Care	71.1	0%	n=37	D+	C-	C-	C	C+	C
	50.0	100.0

Acute Care EMR

Past Acute Care EMR Awards

Contact KLAS

Tell us about your organization

How can we help you?